CVI Holdings’s Peak Bio, Inc. Common Stock PKBO Stock Holding History

CVI Holdings’s Portfolio PKBO Stock Details PKBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-47,225	Closed	-$472K	–	744
2022 Q3	$472K	Buy	47,225 +900	+2%	+$8.94K	0.04%	406
2022 Q2	$457K	Buy	46,325 +2,050	+5%	+$20.2K	0.03%	434
2022 Q1	$436K	Buy	44,275 +4,275	+11%	+$41.9K	0.03%	469
2021 Q4	$390K	Hold	40,000	–	–	0.03%	465
2021 Q3	$392K	Hold	40,000	–	–	0.02%	463
2021 Q2	$387K	Hold	40,000	–	–	0.03%	418
2021 Q1	$388K	Buy	+40,000	New	+$388K	0.03%	388

Other funds holding PKBO

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CVI Holdings's PKBO Position: Q4 2022 in Review

CVI Holdings sold out of Peak Bio, Inc. Common Stock (PKBO) in Q4 2022, closing a stake of 47,225 shares — an estimated $472K sold.

CVI Holdings first reported a position in PKBO in Q1 2021 and held it in 7 quarters. The position peaked at $472K in Q3 2022. 9 funds tracked by Wall St. Rank hold PKBO as of Q4 2022.

CVI Holdings reported no remaining Peak Bio, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
CVI Holdings sold 47,225 Peak Bio, Inc. Common Stock shares in Q4 2022, an estimated $472K.
CVI Holdings first reported a position in Peak Bio, Inc. Common Stock in Q1 2021 and held it in 7 quarters.
CVI Holdings's Peak Bio, Inc. Common Stock position peaked at $472K in Q3 2022.
9 funds tracked by Wall St. Rank held Peak Bio, Inc. Common Stock as of Q4 2022.

Based on CVI Holdings's 13F filing for Q4 2022, filed 14 Feb 2023.